Related Experiment Video

Updated: Jan 13, 2026

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

8.9K

The mouse diaphragm assay in botulinum toxin therapy

Pawel Tacik1, Dirk Dressler2,3

  • 1Department of Parkinson's Disease, Sleep and Movement Disorders, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany. pawel.tacik@ukbonn.de.

Journal of Neural Transmission (Vienna, Austria : 1996)
|January 12, 2026
PubMed
Summary

No abstract available in PubMed .

Keywords:
Botulinum toxinDetectionMouse bioassayMouse diaphragm assayNeutralising antibodiesQuantification

More Related Videos

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

16.5K
Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice07:09

Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice

Published on: September 8, 2011

14.0K

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K